Viscosupplementation: managed care issues for osteoarthritis of the knee [0.03%]
膝骨关节炎黏弹补充疗法的 Managed Care 问题
William Arnold,Dwight S Pete Fullerton,Sharon Holder et al.
William Arnold et al.
Background: Osteoarthritis (OA) affects an estimated 49 million adults in North America, or nearly 1 of every 6 adults. More than 8 million North Americans have limited mobility to some extent because of OA. By 2030, an e...
Craig Jones,Linda Endicott,Michele B Kaufman
Craig Jones
Background: Managed care pharmacists utilize clinical guidelines to assist them in identifying acceptable treatment and management of chronic diseases. For the past several months, an expert panel representing the Nationa...
Steven G Avey
Steven G Avey
Objective: To describe AMCP's Framework for Quality Drug Therapy. Summary: AMCP's Framework for Quality Drug Therapy was designed by a ...
Leadership versus management: translating pharmacists' abilities into quality performance [0.03%]
领导力与管理：将药师的能力转化为高质量的绩效
C E Reeder
C E Reeder
Objective: To describe the quality gap in health care as it was referred to in the Institute of Medicine's reports, to try to harness pharmacy's potential to improve the quality of drug therapy, and to provide insight int...
Byron Cryer
Byron Cryer
Objective: To describe risk factors and review appropriate management strategies for patients who experience nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal (GI) adverse events. ...
Economic considerations in managing patients with chronic stable angina [0.03%]
慢性稳定型心绞痛患者的治疗中的经济考量因素分析
Edith A Nutescu
Edith A Nutescu
Objective: To quantify the economic burden of chronic stable angina in the United States, characterize recent trends in the use of coronary revascularization, and compare the clinical outcomes and long-term costs of percu...
Toby C Trujillo
Toby C Trujillo
Objective: To describe the approved uses, pharmacology, pharmacodynamics, pharmacokinetics, efficacy, safety, and place in therapy of ranolazine, the first new antianginal drug therapy introduced in more than 20 years for...
Paul P Dobesh
Paul P Dobesh
Objective: To describe the epidemiology, impact, pathogenesis, patient presentation, and treatment of stable angina, including the use of vasculoprotective and antianginal drug therapies and coronary revascularization pro...
Best practices in innovative type 2 diabetes program management: a case study [0.03%]
创新的2型糖尿病项目管理的最佳实践：案例研究
H Eric Cannon
H Eric Cannon
Objective: To illustrate, through a case study format, a successful type 2 diabetes disease management program. Summary: Intermountain ...